Overview
Legal name
MY MHEALTH LIMITED
Region
London
Registered address
41 LOTHBURY
LONDON
UNITED KINGDOM
EC2R 7HF
Insolvency history
No
Company
Active
LTD
Company profile
My Mhealth Limited
Digital therapeutics for long-term conditions
my mhealth build evidence based apps and digital therapeutics for patients with COVID-19, COPD, asthma, diabetes and heart disease.
CRN
07881370
Founded
2011
Age
14
Latest accounts
Financial period: 1 Jan 2024 to 31 Dec 2024
FILLETEDACCOUNTS
Turnover
Unknown
Profit / Loss
Unknown
Employees
31
Company events
Reference milestones and recent Companies House filing stream events.
6 events
19 Dec
2026
Confirmation statement due
Confirmation DueNext confirmation statement due date
30 Sep
2026
Accounts due
Accounts DueNext accounts due date
05 Dec
2025
Confirmation statement filed
ConfirmationLast confirmation statement made up date
31 Dec
2024
Accounts filed
AccountsLast accounts made up date
07 Nov
2024
Change Person Director Company With Change Date
OfficersCH01 | Transaction MzQ0MjMzOTUzMmFkaXF6a2N4
Published 07 Nov 2024 08:34
14 Dec
2011
Incorporated
InceptionCompany registered at Companies House
Public funding
3 awards
First funded
2018
Funded years
2018, 2019, 2021
Age at first award
6 years
Projects
2021
EU-Funded
Lead participant
CUOREMA: Immersive Bio & Behavioural Feedback for a Better Heart Health
1 Apr 2021 to 31 Mar 2024
Awarded
£321,405
Total cost £535,416
2019
Knowledge Transfer Partnership
Bournemouth University and My mHealth Limited
1 Apr 2019 to 30 Nov 2020
Awarded
Unknown
To develop a novel prototype for use by patients significantly affected by anxiety, using immersive coaching and mindfulness techniques augmented by virtual reality offering a flexible/scalable platform to deliver powerful interventions to those whose health is affected by stress/anxiety.
2018
Collaborative R&D
Lead participant
Evidence Generation for the Clinical Efficacy and Cost Effectiveness of MyCOPD in patients with mild and newly diagnosed COPD.
1 Jul 2018 to 31 Mar 2019
Awarded
£112,314
Total cost £224,628
"Millions of patients in the UK live with long term medical conditions such as diabetes, heart disease and lung diseases. These conditions are the major cause of ill health in the UK and cost the NHS billions of pounds each year. One long term condition that carries an enormous impact for patients and the NHS is COPD (Chronic Obstructive Pulmonary Disease...
Product types
Collaborative R&D
EU-Funded
Knowledge Transfer Partnership